shutterstock_1899198520_t_schneider
T. Schneider / Shutterstock.com
7 April 2022Big PharmaAlex Baldwin

Qiagen seeks judgment in COVID-19 wastewater testing suit

Qiagen has asked a Delaware court to issue a declaratory judgment that its method for testing for COVID-19 in wastewater does not infringe Bio-Rad’s patents.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
31 August 2021   A US District Court for the District of Delaware jury found that German genetics company Qiagen willfully infringed two patents owned by ArcherDX and Massachusetts General Hospital.
Medtech
9 November 2021   Qiagen will pay Becton, Dickinson $53 million to settle an ongoing patent infringement lawsuit over polymerase chain reaction diagnostics patents.

More on this story

Americas
31 August 2021   A US District Court for the District of Delaware jury found that German genetics company Qiagen willfully infringed two patents owned by ArcherDX and Massachusetts General Hospital.
Medtech
9 November 2021   Qiagen will pay Becton, Dickinson $53 million to settle an ongoing patent infringement lawsuit over polymerase chain reaction diagnostics patents.

More on this story

Americas
31 August 2021   A US District Court for the District of Delaware jury found that German genetics company Qiagen willfully infringed two patents owned by ArcherDX and Massachusetts General Hospital.
Medtech
9 November 2021   Qiagen will pay Becton, Dickinson $53 million to settle an ongoing patent infringement lawsuit over polymerase chain reaction diagnostics patents.